Valuation: DarioHealth Corp.

Market Cap 53.23M 46.54M 42.77M 39.86M 75.61M 5.07B 76.76M 513M 200M 2.49B 200M 196M 8.59B P/E 2026 *
-1.84x
P/E 2027 * -3.75x
Enterprise Value 53.23M 46.54M 42.77M 39.86M 75.61M 5.07B 76.76M 513M 200M 2.49B 200M 196M 8.59B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.39x
Free-Float
78.92%
Yield 2026 *
-
Yield 2027 * -
1 day-1.37%
1 week+5.59%
Current month+8.79%
1 month-4.52%
3 months-5.90%
6 months-46.74%
Current year-36.91%
1 week 6.43
Extreme 6.43
8
1 month 5.84
Extreme 5.8445
8
Current year 5.84
Extreme 5.8445
13.64
1 year 5.84
Extreme 5.8445
17.74
3 years 5.84
Extreme 5.8445
85.2
5 years 5.84
Extreme 5.8445
420
10 years 5.84
Extreme 5.8445
1,998.52
Manager TitleAgeSince
Corporate Officer/Principal - 2011-08-10
Chief Executive Officer 52 2013-08-08
Director of Finance/CFO - 2020-12-31
Director TitleAgeSince
Chairman 52 2014-11-22
Director/Board Member 69 2013-11-11
Director/Board Member 57 2014-11-22
Date Insider Type Main position Quantity % Market Cap.
04-09Other

Director

4,500 0.0616%
25-09-10Free

Director

20,000 0.0440%
25-09-10Free

Chief Financial Officer

5,000 0.0110%
Change 5-day change 1-year change 3-year change Capi.($)
-1.37%+5.59%-48.74%-90.60% 53.23M
-0.80%+1.99%-29.27%-11.79% 166B
-0.92%+1.75%-6.07%-4.32% 106B
-0.44%+4.60%-2.61%+53.29% 57.69B
-1.37%0.00%+53.74%+52.32% 53.78B
-1.73%+0.02%-10.25%-40.04% 43.56B
-1.03%+7.75% - - 36.52B
-0.33%+1.18%-14.63%-44.55% 27.49B
-1.33%+1.79%+63.01%-3.27% 25.84B
-2.31%-0.08%-8.67%-2.46% 21.27B
Average -1.15%+6.04%-0.39%-10.16% 53.89B
Weighted average by Cap. -0.98%+3.80%-4.34%+0.71%

Financials

2026 *2027 *
Net sales 26.16M 22.87M 21.02M 19.59M 37.16M 2.49B 37.72M 252M 98.08M 1.22B 98.19M 96.08M 4.22B 38.23M 33.42M 30.71M 28.63M 54.29M 3.64B 55.12M 369M 143M 1.79B 143M 140M 6.16B
Net income -30.32M -26.5M -24.36M -22.7M -43.06M -2.89B -43.71M -292M -114M -1.42B -114M -111M -4.89B -15.68M -13.71M -12.6M -11.74M -22.28M -1.49B -22.61M -151M -58.8M -734M -58.87M -57.6M -2.53B
Net Debt - -
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Date Price Change Volume
26-07-06 US$6.960 -4.40% 5,592
26-07-02 US$7.280 +7.85% 60,996
26-07-01 US$6.750 +2.27% 10,368
26-06-30 US$6.600 -2.94% 6,046
26-06-29 US$6.800 -3.27% 12,854
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
7.280USD
Average target price
18.50USD
Spread / Average Target
+154.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRIO Stock